OpenAlex
PricingAboutJobs
Log inGet started
Work

35MO Discovery and characterization of selective, FGFR1-sparing, inhibitors of FGFR2/3 oncogenic mutations for the treatment of cancers

HTML

Year: 2021
Type: article
Source: Annals of Oncology
DOI: 10.1016/j.annonc.2021.01.050
Authors: E. Dardenne, F. Padilla, S. Rasmussen, S.N. Yang, A. Mentes, L.S. Ogawa, R. Fiorenza, A. Trombino, S. Smith, D. Romashko, N. Ishiyama, M. Chevtsova, S. Thakur, E. Rosfjord, E. Buck, C. Roberts, M. Lucas, T-A. Lin
Language: English

Topic: Fibroblast Growth Factor Research
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: drug resistance, urothelial carcinoma, cholangiocarcinoma, erdafitinib, pemigatinib, hyperphosphatemia, FGFR tyrosine kinase inhibitors, small molecule inhibitors
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W3133620171
FWCI: 0.065
Cites:
Cited by: 1
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security